ValueVerge
Earnings Report Digest
Discussions on the latest quarterly earnings reports from growth and value stocks.
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
S&P Global Inc. (SPGI), 2024 Q4 earnings digest 12.02.2025 1:50
$SPGI has released its Q4 2024 earnings report, which shows stronger-than-expected results with an EPS of $3.77, exceeding estimates by $0.30, and revenue of $3.59B, representing a 14% increase YoY. Key highlights include notable growth rates across various segments, with Ratings revenue up 27% and a robust demand in Market Intelligence. However, there's cautious optimism due to geopolitical u...
Coca-Cola Company (The) (KO), 2024 Q4 earnings digest 12.02.2025 1:48
$KO reports strong Q4 earnings with EPS of $0.55, beating estimates by $0.03. Revenue reached $11.40B, up 4.17% year-over-year, exceeding expectations by $701.46M. Key stats show a solid valuation with a net debt leverage of 1.8x EBITDA, but currency headwinds remain a risk.
Trending stocks, Feb 11 2025 12.02.2025 1:57
Trending stocks, Feb 11 2025
Vertex Pharmaceuticals Incorpor (VRTX), 2024 Q4 earnings digest 11.02.2025 1:44
$VRTX has released its Q4 2024 earnings report, highlighting a revenue of $2.91B (+15.66% YoY) but an EPS of $3.98, missing estimates by $0.04. Key risks include rising expenses and potential IP issues outside the U.S. As for growth, Vertex is driving expansion with the launch of JOURNA VX and ALYFTREK, paving pathways for increased patient access. Future opportunities focus on penetrating the pai...
McDonald's Corporation (MCD), 2024 Q4 earnings digest 11.02.2025 1:51
$MCD has released Q4 2024 earnings, showing an EPS of $2.83, just missing estimates by $0.03, with revenue at $6.39B, down 0.28% year-over-year. Key highlights include valuation challenges and a tough competition landscape, particularly impacted by a food safety incident.
Trending stocks, Feb 10 2025 11.02.2025 2:34
Trending stocks, Feb 10 2025
Trending stocks, Feb 7 2025 08.02.2025 3:14
Trending stocks, Feb 7 2025
Cloudflare, Inc. (NET), 2024 Q4 earnings digest 07.02.2025 1:50
$NET has released its Q4 2024 earnings, showcasing a strong finish with revenue of $459.9 million, up 27% YoY. Key highlights include an operating profit increase of 69% YoY and a gross margin of 77.6%. However, concerns about customer budget scrutiny persist. 📈
Hilton Worldwide Holdings Inc. (HLT), 2024 Q4 earnings digest 07.02.2025 1:55
$HLT has released its fourth quarter 2024 earnings, showing solid growth with system-wide RevPAR up 3.5% YoY. Key highlights include adjusted EBITDA of $858M (+7%), and a record net unit growth of 7.3% over the year, indicating strong profitability and financial health. Future growth opportunities are evident with an expected 2-3% RevPAR increase for 2025. Risks include potential softness in China...
Air Products and Chemicals, Inc (APD), 2024 Q4 earnings digest 07.02.2025 1:48
$APD has released its fourth-quarter earnings, reporting an adjusted EPS of $3.56, a 13% increase from the previous year, and an adjusted EBITDA margin improvement of 460 bp. Notably, Air Products has completed the $1.8 billion sale of its LNG business to Honeywell. 📈
Fortinet, Inc. (FTNT), 2024 Q4 earnings digest 07.02.2025 2:00
$FTNT has released its fourth quarter earnings, showing strong performance with a record operating margin of 39% and total revenue growth of 17%. However, the billings guidance for Q1 is cautious due to supply chain uncertainties.
Intercontinental Exchange Inc. (ICE), 2024 Q4 earnings digest 07.02.2025 1:47
$ICE has released its fourth quarter earnings, showcasing a record performance. Key highlights include adjusted EPS of $1.52 (up 14% YoY) and net revenues of $2.3 billion, reflecting a 5% increase. Despite strong total revenues, potential risks such as market volatility and regulatory changes linger.
Bristol-Myers Squibb Company (BMY), 2024 Q4 earnings digest 07.02.2025 1:51
$BMY posts its earnings report demonstrating solid execution amidst ongoing challenges. Key highlights include a revenue growth of 9% in Q4 and a focus on operational excellence, with an expected 2025 revenue of ~$45.5 billion. Risks include significant LOEs impacting the legacy portfolio, particularly for Revlimid. Noteworthy projections for non-GAAP EPS are between $6.55 to $6.85. Future growth...
ConocoPhillips (COP), 2024 Q4 earnings digest 07.02.2025 1:48
$COP has released its fourth-quarter 2024 earnings, showcasing solid operational execution. The company reported adjusted earnings of $1.98 per share and generated over $5.4 billion in cash flow. Notable highlights include a 4% year-over-year production growth, bolstered by the recent Marathon acquisition, and a strong capital return strategy targeting $10 billion in shareholder distributions.
Honeywell International Inc. (HON), 2024 Q4 earnings digest 07.02.2025 1:50
$HON just released its Q4 2024 earnings report, highlighting strong performance despite ongoing macroeconomic challenges. The company met or exceeded guidance for organic and adjusted earnings growth. Key stats: Organic sales up 3% for the full year, with a notable backlog of $35.3B and segment margins under pressure due to recent acquisitions and product mix. Looking forward, Honeywell is navigat...
Philip Morris International Inc (PM), 2024 Q4 earnings digest 07.02.2025 1:50
$PM has released its earnings report, showcasing a strong performance in Q4 2024 and overall growth for the year. Key highlights include an organic net revenue growth of +9.8% and a robust +14.9% increase in organic operating income. However, there are currency and supply chain headwinds to address. 📈
Astrazeneca PLC (AZN), 2024 Q4 earnings digest 07.02.2025 1:50
$AZN has released its latest earnings report, showcasing robust growth and developments. Total revenue surged 21% year-over-year, with a core EPS increase of 19%. While the company reported potential risks in China, ongoing investigations could impact their operations. Highlights include steady growth across various therapy areas and expectations of continued innovation. ⚕️💰 Investors should note...
Linde plc (LIN), 2024 Q4 earnings digest 07.02.2025 1:50
$LIN reports solid Q4 results with a flat sales of $8.3B and a margin of 29.9%. ⚖️ Key metrics show 25.9% return on capital and a 10% EPS growth, despite FX headwinds. Valuation aligns with strong historical performance, but future FX risks loom.
Eli Lilly and Company (LLY), 2024 Q4 earnings digest 07.02.2025 1:54
$LLY has just released its Q4 2024 earnings report, highlighting robust revenue growth of 45% compared to Q4 2023, driven by strong performance from Mounjaro and Zepbound. Key risks include the competitive landscape in the incretin market and ongoing pricing pressures.
Amazon (AMZN), 2024 Q4 earnings digest 07.02.2025 1:49
$AMZN has released its Q4 2024 earnings, showing 10% year-over-year revenue growth to $187.8 billion despite a significant foreign exchange headwind. Operating income surged 61% to $21.2 billion, reflecting improved profitability. Key insights reveal strong growth in AWS by 19% YOY and advertising revenue up 18%.
Trending stocks, Feb 6 2025 07.02.2025 2:09
Trending stocks, Feb 6 2025
Johnson Controls International (JCI), 2024 Q4 earnings digest 06.02.2025 1:47
$JCI has released its Q4 fiscal 2024 earnings, showing strong performance with a 10% organic revenue growth and significant margin expansion. Key stats include an adjusted EPS growth of 22% YoY and a robust 96% adjusted free cash flow conversion. Despite risks from restructuring and capital deployment, the future looks promising with a record backlog of $13.1 billion, driven by data center demand....
Ares Management Corporation (ARES), 2024 Q4 earnings digest 06.02.2025 1:52
$ARES has released its earnings report for Q4 and year-end 2024, showcasing a strong performance with notable increases in assets under management (AUM) and fee-related earnings. AUM rose by 16% to over $484 billion, while management fees climbed to a record $781 million. The firm has increased its quarterly dividend by 20%, reflecting confidence in future growth. However, a dynamic market and pot...
Equinor ASA (EQNR), 2024 Q4 earnings digest 06.02.2025 1:46
$EQNR has released its latest earnings report, showcasing a strong quarterly performance. Here's a quick look at the key stats: Return on Capital Employed is at 21%, with cash flow from operations hitting $18 billion. Risks include fluctuating energy prices and geopolitical tensions, but the company remains committed to delivering sustainable growth and competitive returns.
GSK plc (GSK), 2024 Q4 earnings digest 06.02.2025 1:55
🚨 $GSK announces its 2024 earnings results, showcasing a sales increase of 8% to over £31 billion, driven by specialty medicines and significant profit growth📈. Core operating profit rose by 13%, with core EPS up 12%. However, vaccine sales faced challenges, impacting short-term growth forecasts. 💉 The outlook for 2025 anticipates continued robust growth, particularly in specialty medicines, wi...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.